Allstate (ALL)
(Delayed Data from NYSE)
$178.11 USD
-2.84 (-1.57%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $179.99 +1.88 (1.06%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$178.11 USD
-2.84 (-1.57%)
Updated Aug 15, 2024 04:00 PM ET
After-Market: $179.99 +1.88 (1.06%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Zacks News
Founded in 1931 and headquartered in Northbrook, Illinois, The Allstate Corporation is the third-largest property-casualty (P&C) insurer and the largest publicly-held personal lines carrier in the U.S. The company also provides a range of life insurance and investment products to its diverse customer base. It provides insurance products to approximately 16 million households through more than 12,000 exclusive agencies and financial specialists in the U.S. and Canada.
Is It Worth Investing in Allstate (ALL) Based on Wall Street's Bullish Views?
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in Allstate (ALL). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Looking for Finance Stocks? The Zacks Rank Can Help You Find Winners
by Zacks Equity Research
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Zacks Rank.
5 Stocks Trading Near 52-Week High With More Upside Potential
by Vasundhara Sawalka
Investors target stocks that have lately been on a bull run. Stocks like HAS, EAT, DVA, LDOS and ALL are seeing price strength and have a high chance of carrying the momentum forward.
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: The Procter & Gamble, Verizon Communications, Intuitive Surgical, Norfolk Southern and The Allstate
by Zacks Equity Research
The Procter & Gamble, Verizon Communications, Intuitive Surgical, Norfolk Southern and The Allstate are included in this Analyst Blog.
Here's How Insurance ETFs Are Placed Post Q1 Earnings
by Sweta Killa
The decent earnings reports have helped the sector to survive the market rout seen last month.
Top Research Reports for Procter & Gamble, Verizon & Intuitive Surgical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Verizon Communications Inc. (VZ) and Intuitive Surgical, Inc. (ISRG).
ALL vs. PGR: Which Stock Is the Better Value Option?
by Zacks Equity Research
ALL vs. PGR: Which Stock Is the Better Value Option?
Best Momentum Stock to Buy for May 9th
by Zacks Equity Research
NRIM, ALL and MTZ made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 9, 2024.
Ambac Financial Group, Inc. (AMBC) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Ambac (AMBC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
New Strong Buy Stocks for May 9th
by Zacks Equity Research
TNP, CLS, ALL, SRCE and GM have been added to the Zacks Rank #1 (Strong Buy) List on May 9, 2024.
Pick These 5 Lucrative GARP Stocks Using PEG Ratio
by Urmimala Biswas
The GARP approach is for investors who are on the lookout for a mixed investment strategy. MGM, THC, ALL, RCL and EAT are some of the stocks that qualify our screening of GARP stocks.
Should You Invest in the Invesco S&P 500 Equal Weight Financials ETF (RSPF)?
by Zacks Equity Research
Sector ETF report for RSPF
Why Allstate (ALL) is a Top Dividend Stock for Your Portfolio
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Allstate (ALL) have what it takes? Let's find out.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Allstate (ALL) Q1 Earnings Beat on Expanding Auto Premiums
by Zacks Equity Research
Allstate's (ALL) first-quarter results benefit from rate increases and a rise in investment income.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights GigaCloud, Tri Pointe Homes, Pilgrim's Pride, Sunoco and Allstate
by Zacks Equity Research
GigaCloud, Tri Pointe Homes, Pilgrim's Pride, Sunoco and Allstate have been highlighted in this Screen of The Week article.
Compared to Estimates, Allstate (ALL) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Allstate (ALL) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Allstate (ALL) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Allstate (ALL) delivered earnings and revenue surprises of 24.82% and 0.89%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
5 High Earnings Yield Value Stocks to Buy Amid Sticky Inflation
by Rimmi Singhi
Amid market uncertainties, unlock your portfolio value with high earnings yield stocks like GCT, TPH, PPC, SUN and ALP.
Will Rate Hikes Impact Allstate's (ALL) New Business in Q1?
by Zacks Equity Research
Allstate's (ALL) first-quarter results are likely to reflect improved underwriting profitability and moderate loss cost trends.
Has Allstate (ALL) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Here is how Allstate (ALL) and Ameriprise Financial Services (AMP) have performed compared to their sector so far this year.
Exploring Analyst Estimates for Allstate (ALL) Q1 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Allstate (ALL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Allstate (ALL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Allstate (ALL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.